Rosiridin reduces Idiopathic Pulmonary Fibrosis by inhibiting the STAT3/NFκB/SMAD3 signaling pathways
Journal of Pharmacological Sciences · 2025
DOI: 10.1016/j.jphs.2025.09.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacological Sciences, 2025. Verfasst von Yuyao Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Xinjiang Phytomedicine Resource and Utilization Ministry of Education, Institute for Safflower Industry Researc…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Signal Transduction, NF-kappa B, Idiopathic Pulmonary Fibrosis. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project, Xinjiang Production and Construction Corps, Xinjiang Production and Construction Corps Xinjiang Production and Construction Corps.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis is a progressive, highly lethal disease with limited treatment options. It is characterized by fibroblast-to-myofibroblast transformation, excessive ECM proliferation and collagen deposition, leading to the destruction of normal lung architecture and function. As a constituent of Rhodiola rosea L., rosiridin is a monomer with significant structural compatibility, conferring strong therapeutic potential. This bioactive compound mitigates oxidative stress-driven pathology and reverses its resultant damage in various diseases. However, its potential protective effects against bleomycin-induced IPF and the underlying mechanisms remain unclear. This study aimed to investigate the role and mechanism of rosiridin in IPF. Rosiridin attenuated TGF-β1-induced oxidative stress and inflammatory responses in lung epithelial cells and suppressed apoptosis associated with pulmonary fibrosis. Hematoxylin and eosin (HE) staining and Masson's trichrome staining showed that rosiridin improved pathological lung changes, reduced oxidative stress, and alleviated pulmonary fibrosis in a dose-dependent manner. Transcriptomic analysis revealed that rosiridin inhibited JAK protein activation, reduced the transformation of fibroblasts into myofibroblasts, and suppressed the secretion of proinflammatory and profibrotic cytokines. These findings suggest that rosiridin mitigates pulmonary fibrosis through modulation of the STAT3/NF-κB/SMAD3 signaling pathways. Rosiridin may represent a promising therapeutic candidate for the treatment of IPF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Key Laboratory of Xinjiang Phytomedicine Resource and Utilization Ministry of Education, Institute for Safflower Industry Research, Shihezi University, Shihezi, 832002, China.
- Department of Gynecology, Shihezi People's Hospital, Shihezi, 832002, China.
- School of Pharmaceutical Sciences Shenzhen University, Shenzhen, 518060, China.
- School of Pharmacy, Key Laboratory of Xinjiang Phytomedicine Resource and Utilization Ministry of Education, Institute for Safflower Industry Research, Shihezi University, Shihezi, 832002, China. Electronic address: tcm…
- School of Pharmacy, Key Laboratory of Xinjiang Phytomedicine Resource and Utilization Ministry of Education, Institute for Safflower Industry Research, Shihezi University, Shihezi, 832002, China; State-Province Key Labo…
Förderung
- National Science and Technology Major Project
- Xinjiang Production and Construction Corps
- Xinjiang Production and Construction Corps Xinjiang Production and Construction Corps
- National Natural Science Foundation of China
- National Major Science and Technology Projects of China
Zitieren
APA
Li, Y., Qi, H., Xu, H., Jia, X., Chen, W., Pan, R., Pan, X., Wang, H., Yao, D., Zhang, K., & Wang, J. (2025). Rosiridin reduces Idiopathic Pulmonary Fibrosis by inhibiting the STAT3/NFκB/SMAD3 signaling pathways. Journal of Pharmacological Sciences. https://doi.org/10.1016/j.jphs.2025.09.004
Vancouver
Li Y, Qi H, Xu H, Jia X, Chen W, Pan R, et al. Rosiridin reduces Idiopathic Pulmonary Fibrosis by inhibiting the STAT3/NFκB/SMAD3 signaling pathways. Journal of Pharmacological Sciences. 2025. doi:10.1016/j.jphs.2025.09.004
BibTeX
@article{Li2025,
author = {Li, Yuyao and Qi, Huili and Xu, Haoyue and Jia, Xuehai and Chen, Wenyan and Pan, Ruoliu and Pan, Xinhui and Wang, Hangyu and Yao, Dahong and Zhang, Ke and Wang, Jinhui},
title = {Rosiridin reduces Idiopathic Pulmonary Fibrosis by inhibiting the STAT3/NFκB/SMAD3 signaling pathways},
journal = {Journal of Pharmacological Sciences},
year = {2025},
doi = {10.1016/j.jphs.2025.09.004}
}
EUVIMED